Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Epilepsy Res ; 127: 30-39, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27544486

RESUMO

Extracts of Feretia apodanthera Del. (Rubiaceae) have been extensively used in traditional Cameroonian medicine to treat a variety of diseases, including some neurological disorders. The present study was aimed to tests the anticonvulsant properties of the aqueous extract and the alkaloid fraction of the stem barks of Feretia apodanthera. The anticonvulsant investigation was carried out against bicuculline-, picrotoxin-, pentylenetetrazol-, Methyl-ß-carboline-3-carboxylate-, N-Methyl-D-aspartate-, 4-aminopyridine-, and maximal electroshock-induced seizures or turning behavior in mice. The aqueous extract protected mice against bicuculline-, picrotoxin-, pentylenetetrazol-, Methyl-ß-carboline-3-carboxylate-, N-methyl-D-aspartate -, 4-aminopyridine- and maximal electroshock-induced seizures or turning behavior. Also, N-Methyl-D-aspartate-, 4-aminopyridine- and maximal electroshock- induced seizures or turning behavior, were significantly antagonized by the alkaloid fraction (80mg/kg) from Feretia apodanthera. The total protection of mice provided by the aqueous extract against convulsions induced by pentylenetetrazol or picrotoxin was anagonized by flumazenil, a specific antagonist of the benzodiazepine site in the GABAA receptor complex. The aqueous extract of Feretia apodanthera (but not the alkaloid fraction) increased the brain GABA content and inhibited the GABA transaminase activity. In conclusion, Feretia apodanthera was revealed possessing anticonvulsant effects in mice, likely via the GABAergic neurotransmission.


Assuntos
Anticonvulsivantes/farmacologia , Fitoterapia , Extratos Vegetais/farmacologia , Rubiaceae , Convulsões/tratamento farmacológico , 4-Aminobutirato Transaminase/metabolismo , Alcaloides/química , Animais , Anticonvulsivantes/química , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Moduladores GABAérgicos/farmacologia , Masculino , Camundongos , Casca de Planta/química , Extratos Vegetais/química , Receptores de GABA-A/química , Receptores de GABA-A/metabolismo , Água/química
2.
Epilepsy Behav ; 43: 100-8, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25601583

RESUMO

Feretia apodanthera Del. (Rubiaceae) is extensively used in ethnomedicine in Cameroon and Nigeria for epilepsy, febrile convulsions, and rheumatic pains and for enhancing cognitive performance. The aim of the present study was to examine the effects of a lyophilized aqueous extract of F. apodanthera on the course of kindling development, kindling-induced learning deficit, oxidative stress markers, and cholinesterase activity in pentylenetetrazole (PTZ)-kindled mice. Pentylenetetrazole, 30mg/kg, induced kindling in mice after 30.00±1.67days. The aqueous extract of F. apodanthera showed dose-dependent antiseizure effects. Feretia apodanthera (150-200mg/kg) significantly increased the latency to myoclonic jerks, clonic seizures, and generalized tonic-clonic seizures. The extract also improved the seizure score and decreased the number of myoclonic jerks. Pentylenetetrazole kindling induced significant oxidative stress and cognitive impairment which were reversed by pretreatment with F. apodanthera in a dose-dependent manner. The significant decrease in cholinesterase activity observed in the PTZ-kindled mice was reversed by pretreatment with the F. apodanthera extract. The results indicated that pretreatment with the aqueous extract of F. apodanthera antagonizes seizures, oxidative stress, and cognitive impairment in PTZ-kindled mice. The aqueous extract of F. apodanthera also showed anxiolytic activities, but the inhibition of memory impairment was not attributed to the anxiolytic activities of the plant. These results thus suggest the potential of F. apodanthera as an adjuvant in epilepsy both to prevent seizures as well as to protect against seizure-induced oxidative stress and memory impairment.


Assuntos
Transtornos Cognitivos/tratamento farmacológico , Transtornos Cognitivos/psicologia , Cognição/efeitos dos fármacos , Excitação Neurológica/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Rubiaceae/química , Acetilcolinesterase/metabolismo , Animais , Ansiedade/psicologia , Convulsivantes , Liofilização , Masculino , Camundongos , Pentilenotetrazol , Casca de Planta/química , Extratos Vegetais/uso terapêutico , Desempenho Psicomotor/efeitos dos fármacos , Convulsões/induzido quimicamente , Convulsões/prevenção & controle , Convulsões/psicologia
3.
J Urol (Paris) ; 101(2): 93-5, 1995.
Artigo em Francês | MEDLINE | ID: mdl-8522861

RESUMO

Sus-pubic route real time echographic, has allowed to determinate prostatic dimensions (antero-posterior, diameter, APD; mean transversal diameter: MID, cranio candal length CCL) volume and weight in the Black African on 300 subjects. The mean values of these parameter do not differ from European an American values. They increase progressively with age. They are higher in subjects presenting with history of affection of the urinary tract (especially gonococcus urethritis).


Assuntos
População Negra , Próstata/anatomia & histologia , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Criança , Côte d'Ivoire , Humanos , Masculino , Pessoa de Meia-Idade , Tamanho do Órgão , Próstata/diagnóstico por imagem , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...